Scientists Discover Hidden Aggressive Cells Driving Hard to Treat Head and Neck Cancers

Scientists have identified a previously unknown mechanism that drives the growth of aggressive, treatment-resistant head and neck cancers. By mapping the architecture of these tumors, researchers discovered that malignant cells do not just gather at the perimeter of a growth, but can also thrive deep within its center, complicating the biological landscape of the disease.

Mapping the tumor microenvironment

The study, published in Nature Genetics, focuses on squamous cell carcinomas, specifically those that are not linked to the human papillomavirus (HPV). These cancers are notoriously difficult to manage, and the discovery of this secondary, core-based pattern offers a new explanation for their clinical persistence.

Sidharth Puram, a senior author of the study and head of the department of otolaryngology—head and neck surgery at WashU Medicine, describes the finding as a significant shift in the scientific understanding of tumor behavior. By utilizing advanced spatial analysis, the team was able to visualize the tumor ecosystem, identifying a process known as partial epithelial-to-mesenchymal transition (EMT) occurring in two distinct zones.

Diverse triggers for aggressive cell growth

The research revealed that the location of these aggressive cells is dictated by the specific microenvironment surrounding them. While cells at the tumor’s outer edge are activated by interactions with structural fibroblasts, the aggressive cells hidden in the core operate differently. In the tumor’s interior, these cells are triggered by proximity to specialized immune cells known as macrophages.

These macrophages release a protein signal identified as Oncostatin M (OSM), which prompts the cancer cells to adopt a more aggressive, invasive state. According to Puram, identifying this duality is essential for future therapeutic development, as the signals driving growth in the core require different medical interventions than those driving growth at the edge.

Future directions in cancer therapy

Head and neck cancers rank as the sixth most common cancer globally. While the presence of aggressive cells at the tumor periphery is a well-documented phenomenon, the study found that in up to one-third of HPV-negative cases, a distinct core-based distribution pattern exists.

While the work is still in its early stages, the ability to pinpoint these specific cellular triggers provides a clear roadmap for researchers. By developing methods to interrupt the OSM signaling pathway or other localized triggers, scientists hope to create more targeted therapies. The goal is to move beyond broad-spectrum treatments toward precise strategies that address the unique ways these tumors organize and spread within the body.